Literature DB >> 18163993

Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.

Carlos Moran1, Jose L Renteria, Segundo Moran, Joaquin Herrera, Sandra Gonzalez, Jose A Bermudez.   

Abstract

OBJECTIVE: To assess androstenedione (A) and T levels in obese and nonobese patients with polycystic ovary syndrome (PCOS) after GnRH and oral glucose tolerance tests (OGTT).
DESIGN: Cross sectional study.
SETTING: Clinical research center. PATIENT(S): Thirty patients with PCOS, of whom 15 were obese and 15 were nonobese, and 7 women without PCOS were included in the study. INTERVENTION(S): The GnRH test and OGTT were performed in all subjects. MAIN OUTCOME MEASURE(S): Basal and stimulated levels of LH, FSH, insulin, A, and total T were measured. Areas under the curve (AUCs) and AUC change after stimulation for these hormones were calculated. RESULT(S): The basal T levels were significantly higher in obese than in nonobese patients with PCOS. In contrast, the basal levels of A were similar in obese and nonobese patients with PCOS. The T(AUC) after GnRH was significantly greater in obese than in nonobese patients with PCOS but was not significantly different after OGTT. The A(AUC) after GnRH and OGTT was significantly greater in nonobese than in obese patients with PCOS. However, there were no significant differences in T(AUC) and A(AUC) changes after GnRH and OGTT. CONCLUSION(S): A different pattern in the levels of T and A with respect to obesity in PCOS was observed, suggesting a shift in ovarian enzymatic function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18163993     DOI: 10.1016/j.fertnstert.2007.09.016

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation.

Authors:  Kim Sutton-Tyrrell; Xinhua Zhao; Nanette Santoro; Bill Lasley; MaryFran Sowers; Janet Johnston; Rachel Mackey; Karen Matthews
Journal:  Am J Epidemiol       Date:  2010-04-27       Impact factor: 4.897

Review 2.  Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome.

Authors:  Márcia Marly Winck Yamamoto; Sebastião Freitas de Medeiros
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 3.  Polycystic ovary syndrome in the pediatric population.

Authors:  Andrew A Bremer
Journal:  Metab Syndr Relat Disord       Date:  2010-10       Impact factor: 1.894

4.  Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys.

Authors:  W K McGee; C V Bishop; C R Pohl; R J Chang; J C Marshall; F K Pau; R L Stouffer; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-15       Impact factor: 4.310

5.  Obesity differentially affects phenotypes of polycystic ovary syndrome.

Authors:  Carlos Moran; Monica Arriaga; Gustavo Rodriguez; Segundo Moran
Journal:  Int J Endocrinol       Date:  2012-07-08       Impact factor: 3.257

6.  Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients.

Authors:  Parvin Layegh; Zohreh Mousavi; Donya Farrokh Tehrani; Seyed Mohammad Reza Parizadeh; Mohammad Khajedaluee
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-04

7.  Effect of exercise intensity on weight changes and sexual hormones (androstenedione and free testosterone) in female rats with estradiol valerate-induced PCOS.

Authors:  Maryamosadat Miri; Hojatolah Karimi Jashni; Farzaneh Alipour
Journal:  J Ovarian Res       Date:  2014-04-08       Impact factor: 4.234

8.  Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome.

Authors:  Yuying Deng; Yifei Zhang; Shengxian Li; Wenzhong Zhou; Lei Ye; Lihua Wang; Tao Tao; Junjie Gu; Zuwei Yang; Dandan Zhao; Weiqiong Gu; Jie Hong; Guang Ning; Wei Liu; Weiqing Wang
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.